Learning Objectives:

• Discuss the Bridge Model of ED MOUD and its significance in increasing access to evidence-based treatment for individuals with substance use disorders
• Articulate the importance of engaging patients in a more integrated system of care
• Advocate for the expansion of access to evidence-based medication for people who use drugs

Josh Luftig, PA-C
Founder, Director of Harm Reduction Services, CA-Bridge
Josh Luftig, PA-C, has over 23 years of experience in Emergency Medicine, is a co-founder of Bridge, and serves as a Director and National Implementation Leader. He is a nationally recognized expert in medication for addiction treatment (MAT), naloxone distribution, and is a regular speaker at local and national conferences.He co-established one of the nation’s largest ED-based MAT initiation programs at Highland Hospital in Oakland, CA, and co-developed a novel high-dose rapid buprenorphine induction protocol that was published in JAMA and widely adopted as a standard for EDs.